Substituted oxazolidinones for combinational therapy

Details for Australian Patent Application No. 2002312982 (hide)

Owner Bayer HealthCare AG

Inventors Perzborn, Elisabeth; Straub, Alexander; Schlemmer, Karl-Heinz; Pernerstorfer, Josef; Pohlmann, Jens; Rohrig, Susanne; Lampe, Thomas

Agent Davies Collison Cave

Pub. Number AU-B-2002312982

PCT Number PCT/EP02/06237

PCT Pub. Number WO2003/000256

Priority 101 29 725.4 20.06.01 DE

Filing date 7 June 2002

Wipo publication date 8 January 2003

Acceptance publication date 24 January 2008

International Classifications

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

A61K 31/421 (2006.01) - 1,3-Oxazoles, e.g. pemoline, trimethadione

A61K 31/422 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/423 (2006.01) - condensed with carbocyclic rings

A61K 31/427 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/428 (2006.01) - condensed with carbocyclic rings

A61K 31/4365 (2006.01)

A61K 31/4439 (2006.01)

A61K 31/444 (2006.01)

A61K 31/454 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/535 (2006.01) - having six-membered rings with at least one nitrogen and at least one oxygen as the ring hetero atoms, e.g. 1,2-oxazines

A61K 31/5355 (2006.01) - Non-condensed oxazines containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/538 (2006.01)

A61K 31/5383 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61K 45/00 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 7/02 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/04 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/08 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

2 January 2003 Complete Application Filed

  Priority application(s): 101 29 725.4 20.06.01 DE

19 June 2003 Application Open to Public Inspection

  Published as AU-B-2002312982

24 January 2008 Application Accepted

  Published as AU-B-2002312982

22 May 2008 Standard Patent Sealed

14 May 2009 Assignment Registered

  Bayer HealthCare AG The patent has been assigned to Bayer Schering Pharma Aktiengesellschaft

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002312983-METHOD FOR THE PROCESSING OF AT LEAST ONE DIGITAL IMAGE TAKEN WITH A DIGITAL CAMERA AND CAMERA SUITABLE FOR APPLICATION IN SAID METHOD

2002312981-REGULATION OF HUMAN SERINE/ THREONINE PROTEIN KINASE-LIKE ENZYME